Literature DB >> 25387182

Overcoming the reimbursement barriers for clinical sequencing.

Patricia A Deverka1, David Kaufman2, Amy L McGuire3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25387182      PMCID： PMC5087268          DOI： 10.1001/jama.2014.14915

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  First FDA authorization for next-generation sequencer.

Authors:  Francis S Collins; Margaret A Hamburg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

2.  Clinical interpretation and implications of whole-genome sequencing.

Authors:  Frederick E Dewey; Megan E Grove; Cuiping Pan; Benjamin A Goldstein; Jonathan A Bernstein; Hassan Chaib; Jason D Merker; Rachel L Goldfeder; Gregory M Enns; Sean P David; Neda Pakdaman; Kelly E Ormond; Colleen Caleshu; Kerry Kingham; Teri E Klein; Michelle Whirl-Carrillo; Kenneth Sakamoto; Matthew T Wheeler; Atul J Butte; James M Ford; Linda Boxer; John P A Ioannidis; Alan C Yeung; Russ B Altman; Themistocles L Assimes; Michael Snyder; Euan A Ashley; Thomas Quertermous
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

Review 3.  Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment.

Authors:  Judith M E Walsh; James D Goldberg
Journal:  Prenat Diagn       Date:  2013-06       Impact factor: 3.050

4.  ACMG clinical laboratory standards for next-generation sequencing.

Authors:  Heidi L Rehm; Sherri J Bale; Pinar Bayrak-Toydemir; Jonathan S Berg; Kerry K Brown; Joshua L Deignan; Michael J Friez; Birgit H Funke; Madhuri R Hegde; Elaine Lyon
Journal:  Genet Med       Date:  2013-07-25       Impact factor: 8.822

Review 5.  Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.

Authors:  David L Veenstra; Margaret Piper; James E Haddow; Stephen G Pauker; Roger Klein; Carolyn Sue Richards; Sean R Tunis; Benjamin Djulbegovic; Michael Marrone; Jennifer S Lin; Alfred O Berg; Ned Calonge
Journal:  Genet Med       Date:  2012-09-06       Impact factor: 8.822
  5 in total
  14 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 2.  Clinical exome sequencing in neurologic disease.

Authors:  Brent L Fogel; Saty Satya-Murti; Bruce H Cohen
Journal:  Neurol Clin Pract       Date:  2016-04

3.  Insurance companies are slow to cover next-generation sequencing.

Authors:  Shraddha Chakradhar
Journal:  Nat Med       Date:  2015-03       Impact factor: 53.440

4.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

5.  Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Patricia A Deverka; John B Watkins; Kathryn A Phillips
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

6.  Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.

Authors:  Chloe M Reuter; Jennefer N Kohler; Devon Bonner; Diane Zastrow; Liliana Fernandez; Annika Dries; Shruti Marwaha; Jean Davidson; Elly Brokamp; Matthew Herzog; Joyce Hong; Ellen Macnamara; Jill A Rosenfeld; Kelly Schoch; Rebecca Spillmann; Joseph Loscalzo; Joel Krier; Joan Stoler; David Sweetser; Christina G S Palmer; John A Phillips; Vandana Shashi; David A Adams; Yaping Yang; Euan A Ashley; Paul G Fisher; John J Mulvihill; Jonathan A Bernstein; Matthew T Wheeler
Journal:  J Genet Couns       Date:  2019-09-03       Impact factor: 2.537

7.  Payer coverage policies for multigene tests.

Authors:  Kathryn A Phillips; Patricia A Deverka; Julia R Trosman; Michael P Douglas; James D Chambers; Christine B Weldon; Andrew P Dervan
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

8.  Developing context-specific next-generation sequencing policy.

Authors:  Margaret Ann Curnutte; Karen L Frumovitz; Juli M Bollinger; Robert M Cook-Deegan; Amy L McGuire; Mary A Majumder
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

9.  Appropriateness: A Key to Enabling the Use of Genomics in Clinical Practice?

Authors:  Jason L Vassy; David W Bates; Michael F Murray
Journal:  Am J Med       Date:  2016-03-08       Impact factor: 4.965

Review 10.  Recommendations for the integration of genomics into clinical practice.

Authors:  Sarah Bowdin; Adel Gilbert; Emma Bedoukian; Christopher Carew; Margaret P Adam; John Belmont; Barbara Bernhardt; Leslie Biesecker; Hans T Bjornsson; Miriam Blitzer; Lisa C A D'Alessandro; Matthew A Deardorff; Laurie Demmer; Alison Elliott; Gerald L Feldman; Ian A Glass; Gail Herman; Lucia Hindorff; Fuki Hisama; Louanne Hudgins; A Micheil Innes; Laird Jackson; Gail Jarvik; Raymond Kim; Bruce Korf; David H Ledbetter; Mindy Li; Eriskay Liston; Christian Marshall; Livija Medne; M Stephen Meyn; Nasim Monfared; Cynthia Morton; John J Mulvihill; Sharon E Plon; Heidi Rehm; Amy Roberts; Cheryl Shuman; Nancy B Spinner; D James Stavropoulos; Kathleen Valverde; Darrel J Waggoner; Alisha Wilkens; Ronald D Cohn; Ian D Krantz
Journal:  Genet Med       Date:  2016-05-12       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.